Faeth Therapeutics FTH Cash Flow Statement (2019-2026)

NASDAQ FTH
$13.84 +0.91 (+7.08%)
As of: Nov 11, 2026 · 12:09 PM EST
Reported Financials

Faeth Therapeutics Quarterly Cash Flow Statement

Periods 28 quarters
Latest Sep 2026

Faeth Therapeutics reported cash from operations of -$13.00M and free cash flow of -$13.01M for the quarter ended Sep 2026, down 262.6% year over year. This cash flow statement covers 28 quarters of results from Dec 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-9.37M-12.41M-10.54M-13.42M-12.23M-10.18M-9.39M-7.12M-7.41M-7.99M-7.14M-7.25M-7.77M-6.86M-4.94M-4.57M-4.72M-170.24M-16.01M-20.40M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.18M0.18M0.19M0.19M0.20M0.19M0.20M0.19M0.19M0.19M0.19M0.19M0.00M0.01M0.00M0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.33M0.16M0.14M0.15M0.16M0.16M0.14M0.14M0.16M0.14M0.14M0.14M0.19M0.03M0.03M0.03M0.03M0.03M0.03M0.02M
Share-based CompensationStock Comp.
0.83M1.52M1.40M1.48M1.40M1.21M1.10M1.05M1.10M1.22M0.80M0.73M0.39M0.46M0.26M0.25M0.30M12.90M4.48M8.52M
Gains from Sales and DivestituresGains Divest
0.00M0.10M0.20M0.01M0.02M-0.04M0.00M-0.03M
Gains from Investment SecuritiesGains Investment
0.02M
Other non-cash itemsOther Non-Cash
0.26M0.49M0.42M0.26M0.25M-0.03M0.01M0.10M0.22M0.26M0.14M0.12M0.06M0.15M0.17M0.22M0.26M0.30M-0.65M0.05M
Change in Working Capital
Change in Accrued ExpensesChange Accrued Exp.
-2.13M2.64M-3.38M2.94M-0.18M-1.58M-0.44M0.47M-0.78M-0.70M0.33M0.48M0.55M-1.16M0.06M0.38M0.16M2.65M-2.40M1.06M
Change in Other Operating AssetsOther Assets Change
-0.57M1.83M1.03M-1.85M-0.43M1.59M-0.75M-0.43M-0.33M0.66M-0.50M-0.56M-0.54M0.38M-0.06M-0.21M-0.44M-11.19M0.69M1.73M
Change in Other Operating LiabilitiesOther Liabilities Change
0.41M-0.29M-0.28M-0.29M-0.29M-0.27M-0.33M-0.30M-0.37M-0.37M-0.39M-0.47M-0.42M-0.42M-0.38M-0.39M-0.40M-0.41M-0.43M-0.45M
Other Working Capital ChangesOther WC Changes
0.97M-2.12M-1.31M1.57M0.14M-1.86M0.42M0.13M-0.04M-1.03M0.11M0.09M0.13M-0.81M-0.32M-0.18M0.05M10.78M-1.12M-2.18M
Cash from OperationsCash from Ops.
-7.87M-10.75M-11.90M-6.80M-9.57M-11.74M-9.46M-4.66M-6.16M-7.62M-5.79M-5.47M-5.79M-7.09M-5.91M-3.59M-3.86M-10.73M-15.67M-13.00M
Investing Activities
Capital ExpendituresCapex
0.54M0.02M0.05M0.25M0.15M0.03M0.04M0.11M0.02M0.01M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M0.16M0.04M0.21M
Change in Property, Plant and EquipmentChange in PP&E
-0.54M-0.02M-0.05M-0.25M-0.14M0.13M-0.04M-0.11M0.04M0.19M-0.01M0.00M
Acquisitions
-6.46M
Net of Acquisitions & DivestmentsNet Acquisitions
6.46M
Purchase of InvestmentsInvestments Purchased
9.85M8.02M35.25M21.75M-18.15M9.85M0.00M8.69M2.61M6.26M11.73M8.84M17.77M6.35M2.44M9.85M6.52M43.89M114.67M76.82M
Sale and Maturity of InvestmentsInvestments Sold
16.00M20.23M48.50M30.50M-2.11M12.30M19.40M17.00M10.88M12.07M18.75M21.75M14.62M13.50M11.00M11.59M8.60M6.00M6.60M77.00M
Cash from Investing ActivitiesCash from Investing
5.61M12.19M13.20M8.52M16.04M2.31M19.53M8.31M8.26M5.77M6.91M12.91M-3.15M7.19M8.76M1.74M2.08M-31.44M-108.07M0.18M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.23M0.13M0.16M0.16M0.18M0.19M0.19M0.19M0.20M0.20M0.20M0.20M0.21M0.21M0.31M0.15M0.11M0.06M0.02M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.23M-0.13M-0.16M-0.16M-0.18M-0.19M-0.19M-0.19M-0.20M-0.20M-0.20M-0.20M-0.21M-0.21M-0.31M-0.15M-0.11M-0.06M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.23M-0.13M-0.16M-0.16M-0.18M-0.19M-0.19M-0.19M-0.20M-0.20M-0.20M-0.20M-0.21M-0.21M-0.31M-0.15M-0.11M-0.06M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
0.03M0.24M0.02M-0.02M0.00M1.03M0.10M0.10M
Shares Repurchased
2.34M0.25M
Net Shares Issued and RepurchasedNet Shares Issued
0.03M0.24M-2.34M-0.24M-0.02M0.00M1.03M0.10M0.10M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
0.00M200.00M
Net Equity Issued and RepurchasedNet Equity Issued
0.03M0.24M-2.34M-0.24M-0.02M0.00M201.03M0.10M0.10M
Other financing activities (as filed)
-0.13M-0.16M-0.08M-0.01M0.00M0.00M-15.15M-1.76M
Cash from Financing ActivitiesCash from Financing
-0.12M0.12M-0.12M-0.26M-7.95M-2.53M-0.43M-0.21M-0.18M-0.20M-0.19M-0.21M-0.17M-0.15M-0.11M185.83M-1.68M0.10M
Additional items
Change in Cash
-2.37M1.56M1.18M1.55M6.35M-9.69M2.12M1.12M1.67M-2.06M0.94M7.24M-9.14M-0.12M2.68M-2.00M-1.89M143.66M-125.42M-12.72M
Ending Cash Balance
7.16M8.72M9.90M11.45M17.80M8.11M10.23M11.34M13.01M10.96M11.89M19.13M9.99M9.88M12.56M10.56M8.67M152.33M26.90M14.18M
Free Cash FlowFCF
-8.40M-10.77M-11.95M-7.05M-9.57M-11.89M-9.49M-4.66M-6.16M-7.65M-5.90M-5.47M-5.79M-7.09M-5.93M-3.59M-3.86M-10.74M-15.67M-13.01M
Net Cash FlowNCF
-2.37M1.56M1.30M1.71M6.35M-9.69M2.12M1.12M1.67M-2.06M0.94M7.24M-9.14M-0.12M2.68M-2.00M-1.89M143.66M-125.42M-12.72M

Faeth Therapeutics Cash Flow Statement API

Pull Faeth Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FTH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY